HEALTH OF WOMAN. 2018.2(128):31–38; doi 10.15574/HW.2018.128.31

Rudenko A. V. , Pasiechnikov S. P. , Romashchenko O. V. , Samchuk P. O. , Yakovenko L. F.
National Medical University named after O.O. Bohomoltsya, Kyiv
Institute of Urology of the National Academy of Medical Sciences of Ukraine, Kyiv
Institute of Molecular Biology and Genetics of the National Academy of Sciences of Ukraine, Kyiv

In this work we presents the results of the study of local and systemic immunity in 90 women of reproductive age with acute uncomplicated pyelonephritis in combination with inflammatory diseases of the pelvic organs, including the period and duration of the menstrual cycle.
The obtained results allow to say that changes in local immunity play a significant role in the occurrence of acute pyelonephritis, which forms against the background of chronic pelvic inflammatory diseases in the period from the 20th to the 5th day of the menstrual cycle reliably predicting the adverse course of acute uncomplicated pyelonephritis. This provides an opportunity to re-evaluate the principles of prevention of this disease in women of reproductive age, and also timely and justified to prescribe antirecurrent courses of antibacterial and immunocorrective therapy. This approach will enhance the effect of antirecurrent therapy, and to reduce socio-economic losses associated with the treatment and rehabilitation of women of reproductive age.
Key words: acute uncomplicated pyelonephritis, chronic inflammatory diseases of the pelvic organs, menstrual cycle, immunity.

REFERENCES

1. Harding GK, Ronald AR. 1994. The management of urinary infections: what have we learned in the past decade? Int J Antimicrob Agents. 4:83–88. https://doi.org/10.1016/0924-8579(94)90038-8

2. Foxman B. 2014. Urinary tract infection syndromes: occurrence, recurrence, bacteriology, riskfactors, and disease burden. Infect Dis Clin North Am. 28:1–13. https://doi.org/10.1016/j.idc.2013.09.003; PMid:24484571

3. O’Brien VP et al. 2016. Drug and vaccine development for the treatment and prevention of urinary tract infections. Microbiol Spectr. 4. PMid:25517222 PMCid:PMC4365976

in the context of recurrent urinary tract infection. Curr Opin Infect Dis. 2015;28:97–105.

4. O’Brien VP et al. 2015. Are you experienced? Understanding bladder in nate immunity in the context of recurrent urinary tract infection. Curr Opin Infect Dis. 28:97–105. https://doi.org/10.1097/QCO.0000000000000130; PMid:25517222 PMCid:PMC4365976

5. Gupta K et al. 2001. Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections. Ann Intern Med. 135:41–50. https://doi.org/10.7326/0003-4819-135-1-200107030-00012; PMid:11434731

6. Al-Badr A, Al-Shaikh G. 2013. Recurrent urinary tract infections management in women: a review. Sultan Qaboos Univ Med J. 13:359–367. https://doi.org/10.12816/0003256; PMid:23984019 PMCid:PMC3749018

7. Saidakova NO, Startseva LM, Kravchuk NH. 2016. Osnovni pokaznyky urolohichnoi dopomohy v Ukraini za 2014–2015 roky (vidomche vydannia). K:205.

8. Urolohiia. Diiuchi protokoly nadannia medychnoi dopomohy. Naukovo-metodychne vydannia. Za red. SP Pasiechnikova. K, TOV «Doktor-Media». 2011:626.

9. Scholes D, Hooton TM, Roberts PL, Stapleton AE, Gupta K, Stamm WE. 2000. Risk factors for recurrent urinary tract infection in young women. J. Infect Dis. 182(4):1177–1182. https://doi.org/10.1086/315827; PMid:10979915

10. Rudenko AV, Romashchenko OV. 2003. Diahnostyka zapalnykh zakhvoriuvan sechovyvidnykh shliakhiv ta henitalii u zhinok. Zbirnyk naukovykh prats akusheriv-hinekolohiv Ukrainy. K, Intermed:37–42.

11. Ledger W, Witkin S. 2010. Vulvovaginal infection. Manson Pablishin Ltd.: 127.

12. Rudenko AV, Romashchenko OV ta in. 2003. Rol infektsiinykh faktoriv u formuvanni porushen reproduktyvnoho zdorov`ia sim`i. PAH. 2:83–86.

13. Loran OB, Sinyakova LA, Kosova IV. 2008. Sovremennyie podhodyi k diagnostike i lecheniyu ostrogo neobstruktivnogo pielonefrita u zhenschin. Meditsinskiy sovet. 1:59–63.

14. Sinyakova LA. 2002. Gnoynyiy pielonefrit (sovremennaya diagnostika i lechenie). Dis. d-ra med. nauk. M:34–213.

15. Romashchenko OV, Rudenko AV, Lebid LO, Biloholovska VV, Moroz OH. 2004. Kliniko-mikrobiolohichna kharakterystyka zapalnykh zakhvoriuvan orhaniv reproduktyvnoi ta sechovoi systemy. Pediatriia, akusherstvo ta hinekolohiуa 6:80–83.

16. Lebid LO. 2005. Zapalni zakhvoriuvannia henitalii u zhinok z infektsiiamy sechovoi systemy. Pediatriia, akusherstvo ta hinekolohiia 3.

17. Lopatkin NA, Derevyanko II, Nefedova LA. 2000. Etiologicheskaya struktura i lechenie infektsionno-vospalitelnyih oslozhneniy v urologicheskoy praktike. Materialyi Plenuma Rossiyskogo obschestva urologov. Kirov:5–29.

18. Pyitel YuA, Zolotarev II. 1985. Neotlozhnaya urologiya. M, Meditsina:26–45.

19. Karpenko VS, Pereverzev AS. 1976. Klinicheskaya urologiya. K:3–18.

20. Enebaev IU, Boluyants ES. 1989. Kliniko-laboratornaya diagnostika i immunologicheskie osobennosti urogenitalnogo hlamidioza, ureaplazmoza i ih assotsiatsii. Aktualnyie voprosyi besplodnogo braka, obuslovlennogo boleznyami, peredayuschimisya polovyim putem. Sverdlovsk:39–40.

21. Demidov VN, Pyitel YuA, Amosov AV. 1989. Ultrazvukovaya diagnostika v uronefrologii. M, Meditsina:112.

22. Bugrova AA, Abdullaeva SA, Torganova EN. 1999. Osnovnyie svoystva vozbuditelya hlamidioza i ego rol v razvitii infektsiy urogenitalnogo trakta. Zhurnal mikrobiologii, epidemiologii i immunobiologii 4:107–111.

23. Reznichenko HI. 2005. Ratsionalna terapiia vulvovahinitiv zmishanoi etiolohii ta profilaktyka retsydyviv. Ukrainskyi zhurnal dermatolohii, venerolohii, kosmetolohii 1:105–106.

24. Savicheva AM, Bashmakova MA. 1998. Urogenitalnyiy hlamidioz u zhenschin i ego posledstviya. N. Novgorod:3–89.

25. Romashchenko OV, Vozianova SV, Rudenko AV. 2016. Likuvannia zapalnykh zakhvoriuvan orhaniv maloho taza, sprychynenykh mikst-infektsiieiu. Zdorove zhenshchynы 6:34–42.

26. Critchley HO, Kelly RW, Brenner RM, Baird DT. 2001. The endocrinology of menstruation – a role for the immune system. Clin. Endocrinol. (Oxf) 55: 701–710. https://doi.org/10.1046/j.1365-2265.2001.01432.x

27. Lü FX, Ma Z, Rourke T, Srinivasan S, McChesney M, Miller CJ. 1999. Immunoglobulin Concentrations and Antigen­Specific Antibody Levels in Cervicovaginal Lavages of Rhesus Macaques Are Influenced by the Stage of the Menstrual Cycle. Infect. Immun. 67:6321–6328. PMid:10569744 PMCid:PMC97036

28. Johnson SR, Petzold CR, Galask RP. 1985. Qualitative and Quantitative Changes of the Vaginal Microbial Flora During the Menstrual Cycle. Am. J. Reprod. Immunol. Microbiol. 9:1–5. https://doi.org/10.1111/j.1600-0897.1985.tb00331.x; PMid:4051082

29. Schisterman EF, Mumford SL, Sjaarda LA. 2014. Failure to consider the menstrual cycle phase may cause misinterpretation of clinical and research findings of cardiometabolic biomarkers in premenopausal women. Epidemiol. Rev. 36:71–82. https://doi.org/10.1093/epirev/mxt007; PMid:24042431 PMCid:PMC3873842

30. Fahrbach KM, Malykhina O, Stieh DJ, Hope TJ. 2013. Differential binding of IgG and IgA to mucus of the female reproductive tract. PloS one. 8:e76176. https://doi.org/10.1371/journal.pone.0076176; PMid:24098437 PMCid:PMC3788792

31. Wang N, Hammarström L. 2012. IgA deficiency: what is new? Current Opinion in Allergy and Clinical Immunology 12:602–608. https://doi.org/10.1097/ACI.0b013e3283594219; PMid:23026772

32. Abrams ET, Miller EM. 2011. The roles of the immune system in women’s reproduction: Evolutionary constraints and life history trade­offs. Am. J. Phys. Anthropol. 146:134–154. https://doi.org/10.1002/ajpa.21621; PMid:22101690

33. Kwak J, Kwak FM, Gilman­Sachs A, Beaman KD, Cho DD, Beer AE. 2000. Immunoglobulin G infusion treatment for women with recurrent spontaneous abortions and elevated CD56+ natural killer cells. Early pregnancy (Online) 4:154–164.

34. Gundlapalli AV, Scalchunes C, Boyle M, Hill HR. 2015. Fertility, Pregnancies and Outcomes Reported by Females with Common Variable Immune Deficiency and Hypogammaglobulinemia: Results from an Internet­Based Survey. J. Clin. Immunol. 35:125–134. https://doi.org/10.1007/s10875-014-0123-3; PMid:25572592 PMCid:PMC4352195

35. Wira CR, Rodriguez­Garcia M, Patel MV. 2015. The role of sex hormones in immune protection of the female reproductive tract. Nature Reviews Immunology. https://doi.org/10.1038/nri3819; PMid:25743222 PMCid:PMC4716657

36. Stamm WE et al. 1993. Management of urinarytract infections in adults. N Engl J Med. 329(18):1328–34. https://doi.org/10.1056/NEJM199310283291808; PMid:8413414

37. Ventskovskiy BM, Tovstanovskaya VA, Yankovskiy DS. 2002. Mikroekologicheskie aspektyi reproduktivnogo zdorovya zhenschinyi i sovremennyie podhodyi k ego podderzhaniyu. Zdorove zhenschinyi 3 (11).

38. Bugrova AA, Abdullaeva SA, Torganova EN. 1999. Osnovnyie svoystva vozbuditelya hlamidioza i ego rol v razvitii infektsiy urogenitalnogo trakta. Zhurnal mikrobiologii, epidemiologii i immunobiologii 4:107–111.

39. Yankovskiy DS. 2005. Mikrobnaya ekologiya cheloveka. Sovremennyie vozmozhnosti ee podderzhaniya i vosstanovleniya mikrofloryi. K, Ekspert LTD:362.

40. Yankovskiy DS. 2003. Sostav i funktsii mikrobiotsenozov razlichnyih biotopov cheloveka. Tekst. Zdorove zhenschinyi 4(16):145–158.

41. Sadeghi Nejad H, Wasstrman M, Weidner W, Richardsson D, Goldmeier D. 2010. Sexually Transmitted Diseases and sexual function. Journal of Sexual Medicine. 7:389–413. https://doi.org/10.1111/j.1743-6109.2009.01622.x; PMid:20092446

42. Grazziotti A. Menstrual bleeding: pathophisiology and comorbidity. 2012, October 7. International Federation of Gynecology and Obstetrics World Congress of Gynecology and Obstetrics.  Roma, Italy. 12.

43. Berbic M еt all. 2014. Inflammation and endometrial bleeding. Climacteric. 17:47–53. https://doi.org/10.3109/13697137.2014.963964; PMid:25247830

44. Gopchuk EN, Gerasimova TV. 2016. Menstrualnyiy tsikl i ego svyaz s sistemnyim vospaleniem. Zdorove zhenschiny 3(109):99–102.

45. Hooton TM, Winter C, Tiu F and Stamm WE. 1996. Association of acute cystitis with the stage of the menstrual cycle in young women. Clin. Infect. Dis. 23:635–636. https://doi.org/10.1093/clinids/23.3.635; PMid:8879792

46. Lüthje P, Brauner H, Ramos NL, Övregaard A, Gläser R, Hirschberg AL et al. 2013. Estrogen supports urothelial defense mechanisms. Sci. Transl. Med. 5(190ra80).

47. Imamov O, Yakimchuk K, Morani A, Schwend T, Wada­Hiraike O, Razumov S et al. 2007. Estrogen receptor beta­deficient female mice develop a bladder phenotype resembling human interstitial cystitis. Proc. Natl. Acad. Sci USA. 104:9806–9809. https://doi.org/10.1073/pnas.0703410104; PMid:17522255 PMCid:PMC1887607

48. Teng J, Wang ZY, Jarrard DF and Bjorling DE. 2008. Roles of estrogen receptor alpha and beta in modulating urothelial cell proliferation. Endocr. Relat. Cancer. 15:351–364. https://doi.org/10.1677/erc.1.01255; PMid:18310301 PMCid:PMC3513362

49. Jilma B, Dirnberger E, Löscher I, Rumplmayr A, Hildebrandt J et al. 1997. Menstrual cycle-associated changes inblood levels of interleukin-6, alpha1acid glycoprotein, and C-reactive protein. The Journal of laboratory and clinical medicine. 130:69. https://doi.org/10.1016/S0022-2143(97)90060-3

50. Urolohiia: pidruchnyk dlia studentiv vyshchykh medychnykh navchalnykh zakladiv. Za red. Pasiechnikova SP. Vinnytsia, Nova knyha. 2013:432.

51. Grabe M, Bjerklund­Johansen TE, Botto N et al. 2016. Guidelines EAU: guidelines on urological infections: 106.

52. Mancini G, Carbonara AO & Heremans JF. 1965. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry 2:235–54. https://doi.org/10.1016/0019-2791(65)90004-2

53. Kiselev VI. 2000. Polimeraznaya tsepnaya reaktsiya v diagnostike urogenitalnyih infektsiy. Posobie dlya vrachey. M:16–32.

54. Zemskov AM, Privorotov VM, Zemskov VM. 1984. Korrektsiya nukleinatom natriya vtorichnoy immunologicheskoy nedostatochnosti u bolnyih s hronicheskim zabolevaniem vnutrennih organov: Metodicheskie rekomendatsii. Voronezh:24.